Liang Kang

32PUBLICATIONS
59CO-AUTHORS
Tumour immunologyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Apr 20, 2026
SIRT1 Inhibits T Cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance.

|Mar 27, 2026
Lactylation at lysine 145 fosters KAT8-TIP60 complex formation to promote p53 acetylation at lysine 120 and its pro-apoptotic function.

Huashan Liu, Ze Li, Dongxu Lei

|Jan 21, 2026
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial.

Xiaobin Zheng, Huashan Liu, Lishuo Shi

|Oct 28, 2025
Dynamic Arginine Methylation of YBX1 Relay Controls Its Phase Separation and Chemoradiotherapy Resistance in Rectal Cancer.

Yunxing Shi, Taixuan Wan, Shaoru Liu

|Apr 02, 2025
Transanal endoscopic local resection versus radical excision in the treatment of massive rectal gastrointestinal stromal tumors: striving for therapeutic advantages.

Taixuan Wan, Jingkun Xiao, Xingwei Zhang

|Jan 01, 2025
Glutamic-pyruvic transaminase 1 deficiency-mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression.

Li Xiong, Xin Yang, Huashan Liu

Pageof 6

Frequent Collaborators

9 joint publications

Ziwei Zeng

8 joint publications

Huashan Liu

5 joint publications

Xiaobin Zheng

3 joint publications

Yanhong Deng